Ceramides in Adipose Tissue

Adipose tissue is a key nutrient-sensing depot that regulates excess energy storage and consumption. Adipocytes, the key components of the adipose tissue, have unique ability to store excess energy in the form of triglycerides, sense systemic energy demands, and secrete factors (lipids, peptides, cy...

Full description

Bibliographic Details
Main Authors: Ying Li, Chad Lamar Talbot, Bhagirath Chaurasia
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2020.00407/full
_version_ 1818020447264964608
author Ying Li
Chad Lamar Talbot
Bhagirath Chaurasia
Bhagirath Chaurasia
author_facet Ying Li
Chad Lamar Talbot
Bhagirath Chaurasia
Bhagirath Chaurasia
author_sort Ying Li
collection DOAJ
description Adipose tissue is a key nutrient-sensing depot that regulates excess energy storage and consumption. Adipocytes, the key components of the adipose tissue, have unique ability to store excess energy in the form of triglycerides, sense systemic energy demands, and secrete factors (lipids, peptides, cytokines, and adipokines) to regulate other metabolic tissues. The presence of various types of adipocytes (white, brown, and beige) characterized by the number/size of lipid droplets, mitochondrial density, and thermogenic capacity, further highlights how intricate is the communication of these cell-types with other metabolic tissues to sense nutrients. In obesity the inherent capacity of adipose tissue to store and sense nutrients is compromised, causing spillover of the intermediate lipid metabolites into circulation and resulting in their ectopic deposition in tissues not suitable for lipid storage, a phenomenon known as lipotoxicity. This results in a spectrum of cellular dysfunction, that underlies various metabolic diseases. Of the numerous lipid classes implicated in eliciting lipotoxicity, sphingolipid: ceramides are among the most deleterious as they modulate signaling pathways involved in regulating glucose metabolism, triglyceride synthesis, apoptosis, and fibrosis. Notably, recent experimental studies have strongly implicated ceramides in the development of numerous metabolic diseases such as insulin resistance, diabetes, cardiomyopathy, hepatic-steatosis, and atherosclerosis. Herein we discuss and summarizes recent findings that implicate ceramides as a key contributor to adipocyte dysfunction underlying metabolic diseases and how depletion of ceramides can be exploited to improve metabolic health.
first_indexed 2024-04-14T08:06:27Z
format Article
id doaj.art-a19d32f93c884826ba0b2f89144e9b61
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-14T08:06:27Z
publishDate 2020-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-a19d32f93c884826ba0b2f89144e9b612022-12-22T02:04:44ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922020-06-011110.3389/fendo.2020.00407555393Ceramides in Adipose TissueYing Li0Chad Lamar Talbot1Bhagirath Chaurasia2Bhagirath Chaurasia3Department of Nutrition and Integrative Physiology, The Diabetes and Metabolism Research Center, University of Utah, Salt Lake City, UT, United StatesDepartment of Nutrition and Integrative Physiology, The Diabetes and Metabolism Research Center, University of Utah, Salt Lake City, UT, United StatesDepartment of Nutrition and Integrative Physiology, The Diabetes and Metabolism Research Center, University of Utah, Salt Lake City, UT, United StatesDivision of Endocrinology, Department of Internal Medicine, Fraternal Order of Eagles Diabetes Research Center, Carver College of Medicine, University of Iowa, Iowa City, IA, United StatesAdipose tissue is a key nutrient-sensing depot that regulates excess energy storage and consumption. Adipocytes, the key components of the adipose tissue, have unique ability to store excess energy in the form of triglycerides, sense systemic energy demands, and secrete factors (lipids, peptides, cytokines, and adipokines) to regulate other metabolic tissues. The presence of various types of adipocytes (white, brown, and beige) characterized by the number/size of lipid droplets, mitochondrial density, and thermogenic capacity, further highlights how intricate is the communication of these cell-types with other metabolic tissues to sense nutrients. In obesity the inherent capacity of adipose tissue to store and sense nutrients is compromised, causing spillover of the intermediate lipid metabolites into circulation and resulting in their ectopic deposition in tissues not suitable for lipid storage, a phenomenon known as lipotoxicity. This results in a spectrum of cellular dysfunction, that underlies various metabolic diseases. Of the numerous lipid classes implicated in eliciting lipotoxicity, sphingolipid: ceramides are among the most deleterious as they modulate signaling pathways involved in regulating glucose metabolism, triglyceride synthesis, apoptosis, and fibrosis. Notably, recent experimental studies have strongly implicated ceramides in the development of numerous metabolic diseases such as insulin resistance, diabetes, cardiomyopathy, hepatic-steatosis, and atherosclerosis. Herein we discuss and summarizes recent findings that implicate ceramides as a key contributor to adipocyte dysfunction underlying metabolic diseases and how depletion of ceramides can be exploited to improve metabolic health.https://www.frontiersin.org/article/10.3389/fendo.2020.00407/fullmetabolismadipocytesdiabetesinsulinceramides
spellingShingle Ying Li
Chad Lamar Talbot
Bhagirath Chaurasia
Bhagirath Chaurasia
Ceramides in Adipose Tissue
Frontiers in Endocrinology
metabolism
adipocytes
diabetes
insulin
ceramides
title Ceramides in Adipose Tissue
title_full Ceramides in Adipose Tissue
title_fullStr Ceramides in Adipose Tissue
title_full_unstemmed Ceramides in Adipose Tissue
title_short Ceramides in Adipose Tissue
title_sort ceramides in adipose tissue
topic metabolism
adipocytes
diabetes
insulin
ceramides
url https://www.frontiersin.org/article/10.3389/fendo.2020.00407/full
work_keys_str_mv AT yingli ceramidesinadiposetissue
AT chadlamartalbot ceramidesinadiposetissue
AT bhagirathchaurasia ceramidesinadiposetissue
AT bhagirathchaurasia ceramidesinadiposetissue